What direct-to-employer GLP-1 purchasing means for primary care physicians

News Highlights

Andel is among companies selling brand-name drugs directly to employers, bypassing pharmacy benefit managers and insurers. Medical Economics spoke with founder and CEO Jay Bregman about the model and what physicians should keep in mind.

Andel is among a growing number of companies that sell brand-name drugs directly to employers, skipping pharmacy benefit managers and insurers. Medical Economics spoke with founder and CEO Jay Bregman to better understand how the model works and what physicians should keep in mind.